"Privacy Concerns Raised Over C.D.C.'s H.I.V. Sample Tracking"
H.I.V. advocacy groups have raised concerns about the Centers for Disease Control and Prevention's practice of tracking genetic signatures of viruses from newly diagnosed H.I.V. patients, citing potential privacy violations and civil rights issues. While the C.D.C. has revised its guidelines to encourage more transparency, some advocates feel that the changes are not sufficient to protect patients, especially in states where H.I.V. transmission can lead to prosecution. The C.D.C. defends the program, emphasizing its benefits in guiding treatment decisions, but the debate continues over the balance between public health surveillance and individual privacy rights.
